U.S. District Judge John M. Gallagher for the Eastern District of Pennsylvania denied defendant Patient First Pennsylvania Medical Group's motion for summary judgment on physician Brent Nickischer's ...

Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program. The alliance ...